Abstract
Background: Allergic rhinitis and bronchial asthma are inflammatory conditions that have increased in prevalence over the past two decades; studies of the inflammatory response in these diseases have determined that T regulatory cells (Treg) have been considered as responsible for allergens tolerance. The expression of CTLA-4 (CD152) in Treg is associated with the functional activity of this population, moreover the expression of 4-1BB (CD137) has a controversial function.
Objective: To determine the existence of CTLA-4 and 4-1BB in Treg cells in peripheral blood of patients with rhinitis and/or asthma.
Material and method: A comparative cross-sectional study was done with three groups of patients: 20 subjects with allergic rhinitis, 17 subjects with bronchial asthma and 17 subjects with both disorders; 19 healthy subjects conformed the control group. The frequency of Treg (CD4+, FoxP3+ and CD25hight) and the expression of CD152 and CD137 in these cells were assessed by flow cytometry in peripheral blood.
Results: We found that the group of subjects with bronchial asthma (p<0.001) and allergic rhinitis bronchial asthma (p<0.001) showed a significantly lower percentage of Treg (CD4+, CD25hight and FoxP3+) in peripheral blood compared to the healthy subjects controls. Only the group of subjects with bronchial asthma showed a significantly higher percentage of CD152+ (p<0.01) and CD137+ (p<0.01) Treg compared to control group.
Conclusions: Subjects with bronchial asthma and bronchial asthma and allergic rhinitis disorders have a deficiency of CD4+, CD25hight and FoxP3+ Treg in peripheral blood; however, subjects with bronchial asthma had a higher frequency of CD152+ and CD137+ Treg cells.
References
Bousquet J, Reid J, van WC, Baena CC, et al. Allergic rinitis management pocket reference 2008. Allergy 2008;63:990-996.
Bousquet J, Burney PG, Zuberbier T, Cauwenberge PV, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy 2009;64:969-977.
Cagnani CE, Sole D, Diaz SN, Zernotti ME, et al. Allergic rhinitis update and its impact on asthma (ARIA 2008). Latin American perspective. Rev Alerg Mex 2009;56:56-63.
Lopez PG, Morfin Maciel BM, Huerta LJ, Mejia CF, et al. Prevalence of allergic diseases in Mexico City. Rev Alerg Mex 2009;56:72-79.
Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America Survey. J Allergy Clin Immunol 2009;124:43-70.
Nandakumar S, Miller CW, Kumaraguru U. T regulatory cells: an overview and intervention techniques to modulate allergy outcome. Clin Mol Allergy 2009:7:5.
Robinson DS. Regulatory T cells and asthma. Clin Exp Allergy 2009;39:1314-1323.
Shi HZ, Qin XJ. CD4CD25 regulatory T lymphocytes in allergy and asthma. Allergy 2005;60:986-995.
Thunberg S, Gafvelin G, Nord M, Gronneberg R, et al. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Allergy 2010;65:311-318.
Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001;19:225-252.
Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996;183:2533-2540.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.
Read S, Greenwald R, Izcue A, Robinson N, et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 2006;177:4376-4383.
Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell. Nat Rev Immunol 2003;3:609-620.
Kwon B, Moon CH, Kang S, Seo SK, Kwon BS. 4-1BB: still in the midst of darkness. Mol Cells 2000;10:119-126.
Vinay DS, Kwon BS. Role of 4-1BB in immune responses. Semin Immunol 1998;10:481-489.
Polte T, Foell J, Werner C, Hoymann HG, et al. CD137- mediated immunotherapy for allergic asthma. J Clin Invest 2006;116:1025-1036.
Elpek KG, Yolcu ES, Franke DD, Lacelle C. Ex vivo expansión of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 2007;179:7295-7304.
Zheng G, Wang B, Chen A. The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells. J Immunol 2004;173:2428-2434.
So T, Lee SW, Croft M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB. Cytokine Growth Factor Rev 2008;19:253-262.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2015 Revista Alergia México